J&J Wins Patent Fight Over Drug Stent
A drug-eluting stent distributed by a Johnson & Johnson Inc. subsidiary does not infringe on a Boston Scientific Corp. patent for a method of administering drugs to treat heart disease, a...To view the full article, register now.
Already a subscriber? Click here to view full article